The pulmonary drug delivery systems market is poised for significant growth over the forecast period from 2024 to 2034. As a critical method for delivering medications directly to the lungs, pulmonary drug delivery systems are increasingly used for treating respiratory diseases such as asthma, COPD (chronic obstructive pulmonary disease), and other pulmonary disorders. With ongoing...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian